by James Lyons-Weiler, Ph.D., Childrens Health Defense:
The U.S. Food and Drug Administration published a report to justify authorizing COVID-19 vaccines for infants and toddlers, but the report is just more of the same: exaggerating the risk of the virus and minimizing the perception of the risk posed by the vaccines.
Editor’s Note: The U.S. Food and Drug Administration’s vaccine advisory council will meet June 14 to consider granting Emergency Use Authorization (EUA) of the Pfizer and Moderna COVID-19 vaccines for children under 5 years old, even though the White House last week announced it is already filling orders for the vaccines placed by states and healthcare providers. Click here to tell your members of Congress to oppose EUA of these vaccines for young children.
As promised, the U.S. Food and Drug Administration (FDA) has ginned up a report that ostensibly will be used to try to justify “approval” (whatever they mean by that now) of COVID-19 vaccines for infants and toddlers (children < 5 years old).
It is not hard to see what shenanigans the FDA has been up to — to try to bolster a vaccine that fewer and fewer adults want. It’s more of the same: exaggerating the apparent risk of the virus and minimizing the perception of risk posed by the vaccines.
In other words, lies.
1. There is no evidence of clinical urgency.
Infants and toddlers (and children in general) do not get COVID-19; they do not (yet) die from COVID-19.
All that can change when antibody-dependent enhancement kicks in for the vaccinated.
The FDA’s own reports cite 1,086 deaths “from COVID-19” and 10,700,000 “cases” of COVID-19 in children aged 0-17. There have been 832 days since April 1, 2020, when diagnoses started for COVID-19.
For the entire population of children in the U.S. (73,000,000), the risk of COVID-19 infection since the onset of COVID is 10,700,000/73,000,000 = 0.14657.
The risk of a child dying if they have a diagnosis is 1,086/10,700,00 or 1086/10700000 = 0.00010149532. The risk of any child dying of COVID-19 over this time period is 1,086/73000000 = 0.00001487671.
The per-day risk is on the order of 1.78806611e-8 (0.000000001788). There is no real unmet clinical need and the FDA needs to go back to college to understand how to use RT-PCR correctly. Children do not get COVID-19, and they do not die.
2. Inconsistent use of the idea ‘vaccinated.’
This has been the pattern from the very first study. The FDA, the Centers for Disease Control and Prevention, Moderna, Pfizer and others pull out whatever definition of “vaccinated” they want.
Examples: “Vaccinated” is defined in the original trials as people who received both doses and who did not develop COVID-19 before two weeks passed after the second exposure to the vaccine.
In fact, that means that people who developed COVID-19 due to disease enhancement were dropped from the study calculations.
First, this is the first time people were dropped from a vaccine trial for getting infected with the pathogen targeted by the vaccine up to 13 or 14 days after being vaccinated.
Second, it’s actually five entire weeks — one month and one week — 44 days — after the first exposure. ALL of the vaccine efficacy being cited by the FDA is suspect.
Moderna’s and Pfizer’s vaccines never achieved >90% true vaccine efficacy; the best estimate is more like 75%.
3. Inconsistent use of the idea ‘vaccine efficacy.’
Over the time period since the first COVID-19 vaccine trials, various definitions of “vaccine efficacy” have been used.
Decreased transmission. Reduction in infection rates. Reduced hospitalization. Presence of neutralizing antibodies. Presence of antibodies.
All are used and cited in the FDA’s report whenever convenient, all in an ad-hoc manner. It’s more than irritating. It’s moving the goal post and represents reckless (and ineffective) attempts to manipulate public perception.
This practice continues in the reports and studies that are cited by the FDA. I do not trust the efficacy data the FDA cites in their report.
Further evidence of the futility of the evidence used to claim efficacy comes from Moderna’s Sponsor Briefing report to the FDA:
“3.3 Regulatory Considerations for Clinical Development of COVID-19 Vaccines in Children
“Regulatory precedent with other preventive vaccines provides a basis for inference of vaccine effectiveness in pediatric populations based on immunobridging to a young adult population in which clinical disease endpoint vaccine efficacy has been demonstrated for the same prototype vaccine. The immune marker(s) used for immunobridging do not need to be scientifically established to predict protection but should be clinically relevant to the disease.
“Based on available data in humans and animal models, FDA considers neutralizing antibody titers (a functional measure of the vaccine immune response against SARS-CoV-2) to be clinically relevant for immunobridging to infer effectiveness of COVID-19 vaccines in pediatric age groups.
“Because no specific neutralizing antibody titer has been established to predict protection against COVID-19, two immunogenicity endpoints (GMT and SRR) are considered appropriate for comparing the range of neutralizing antibody responses elicited by the vaccine in pediatric versus young adult populations.”
Also embedded in this piece of work is the fact that the FDA does not need evidence of long-term immunity; they are settling for something called “immunobridging” — guessing at the efficacy of a vaccine in one clinical population from measurements made from other clinical populations.
They also are making people dependent on vaccines … expecting patients to have antibodies from one vaccine to the next. This makes no sense immunologically. We don’t need continuously high antibody levels against any pathogen.
We have memory B-cells and T-cells. In accepting this paradigm, the FDA is completely off its rocker and will cause immune exhaustion with constant vaccinations every three to four months.
4. Incomplete consideration of the scientific data (Barnstable County, Israel, Ontario).
We know that months after vaccination, those who are vaccinated are at higher risk of infection and now of hospitalizations.
According to Jeremy Hammond, data show “vaccine effectiveness (VE) in children becomes(sic) negative within several months since receipt of the second dose.in children.”
“Researchers from the New York State Department of Health published a study on the preprint server medRxiv on February 28 noting that the evidence for vaccine effectiveness in children, particularly those aged five to eleven, was ‘limited.’
“So, they aimed to provide data to inform policymaking.
“‘During Omicron variant predominance,’ the authors concluded, ‘VE against infection declined rapidly’ for young children in the state of New York, ‘with low protection by one month following full-vaccination.’
“Comparing COVID-19 cases during January between unvaccinated and vaccinated children, they estimated initial vaccine effectiveness for children aged twelve to seventeen to be 76 percent, but this dropped to below 50 percent after just five weeks since receipt of the second dose.
“Moreover, for young children (aged five to eleven), they observed a drop from 65 percent to just 12 percent after only one month.
“Thereafter, their estimate indicated significantly negative effectiveness for this age group, as shown in Figure 2 of their paper: by 35 to 41 days, VE reached negative 10 percent, and by 42 to 48 days, it reached negative 41 percent.”
Jeremy goes on to report (correctly) that the authors of the article misinterpreted their own data. History will remember Jeremy as a reporter with great integrity.
5. Moderna and Pfizer reports fail to study long-term risks.
Why day 28? Why not “since the vaccine has been administered” to more accurately reflect the real-world clinical situation?
They also state that myocarditis is a large concern in people infected with SARS-CoV-2 — but the comparison is to the uninfected, not the vaccinated, and we know that the spike protein is the cause (syncytia among heart muscles caused by the spike protein).
The spike protein, of course, is the basis of their mRNA vaccines.
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.